AR101124A1 - Bacterias modificadas para vacunas mejoradas contra la brucelosis - Google Patents

Bacterias modificadas para vacunas mejoradas contra la brucelosis

Info

Publication number
AR101124A1
AR101124A1 ARP150102171A ARP150102171A AR101124A1 AR 101124 A1 AR101124 A1 AR 101124A1 AR P150102171 A ARP150102171 A AR P150102171A AR P150102171 A ARP150102171 A AR P150102171A AR 101124 A1 AR101124 A1 AR 101124A1
Authority
AR
Argentina
Prior art keywords
brucelosis
vaccines against
modified bacteria
improved vaccines
inactivated
Prior art date
Application number
ARP150102171A
Other languages
English (en)
Original Assignee
Inserm (Institut Nat De La Santé Et De La Rech Médicale)
Centre Nat De La Rech Scient (Cnrs)
Université Daix-Marseille
Univ Navarra
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inserm (Institut Nat De La Santé Et De La Rech Médicale), Centre Nat De La Rech Scient (Cnrs), Université Daix-Marseille, Univ Navarra filed Critical Inserm (Institut Nat De La Santé Et De La Rech Médicale)
Publication of AR101124A1 publication Critical patent/AR101124A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Bacteria modificada perteneciente al género Brucella, que porta un gen wadC inactivado y un gen ppdK inactivado, y a usos de la misma. También una vacuna contra la brucelosis en humanos y/o animales que comprende una bacteria modificada perteneciente al género Brucella, que porta un gen wadC inactivado y un gen ppdK inactivado.
ARP150102171A 2014-07-10 2015-07-07 Bacterias modificadas para vacunas mejoradas contra la brucelosis AR101124A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14306125 2014-07-10

Publications (1)

Publication Number Publication Date
AR101124A1 true AR101124A1 (es) 2016-11-23

Family

ID=51224890

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150102171A AR101124A1 (es) 2014-07-10 2015-07-07 Bacterias modificadas para vacunas mejoradas contra la brucelosis

Country Status (1)

Country Link
AR (1) AR101124A1 (es)

Similar Documents

Publication Publication Date Title
CY1122162T1 (el) Συνθεσεις που περιεχουν bakthpiaka στελεχη
CL2018000432A1 (es) Vacunas terapéuticas contra el hpv18
AR095233A1 (es) Métodos y composiciones para el control de malezas
CL2012003299A1 (es) Vacuna que comprende uno o mas antigenos, uno o mas oligonucleotidos inmunoestimuladores aislados y colesterol; metodo para inducir una respuesta inmune antigeno específica en un sujeto que necesita de la misma.
AR102527A1 (es) Vacunas terapéuticas para hpv16
BR112016023707A2 (pt) método para produzir l-aminoácidos com o uso de uma bactéria alcalifílica
CR20160502A (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso
HK1254806A1 (zh) 包含一種或多種群體表位基共序列抗原的hiv疫苗
BR112014033046A2 (pt) linhagem mutante atenuada de salmonella typhi, vacina de dna e vacina de dna vxm01
BR112014032636A2 (pt) Vacinas atenuadas de streptococcus suis e métodos de produção e usos das mesmas
BR112015025748A2 (pt) construção de dna para imunomodulação, composição farmacêutica, vacina, e uso de uma construção de dna
MY191539A (en) Streptococcal vaccine
CL2018001279A1 (es) Spodoptera frugiperda resistente a vip3a.
BR112017014598A2 (pt) métodos e usos para hidrólise de queratina
MX2016014558A (es) Extinguidores de fluorescencia "cosmic quenchers".
EP3208747A4 (en) Two-dimensional code generating method, two-dimensional code generating device, program, two-dimensional code, two-dimensional code reading method, and two-dimensional code reading device
MA43517A (fr) Vaccin multivalent contre m. hyo et ses utilisations
UY36208A (es) “bacterias modificadas para vacunas mejoradas contra la brucelosis”.
MX371363B (es) Metodos de deteccion y cuantificacion de bacterias contenidas en o dentro de goma de mascar.
CL2016001906A1 (es) Vacunas contra el reovirus aviar.
EP4226936A3 (en) Non-neuroinvasive viruses and uses thereof
MX2015015428A (es) Eliminacion de riesgo de narcolepsia en vacunas contra influenza.
PE20190225A1 (es) Un metodo para reducir la contaminacion de huevo
AR101124A1 (es) Bacterias modificadas para vacunas mejoradas contra la brucelosis
BR112018013400A2 (pt) vacina marcadora de pestivírus

Legal Events

Date Code Title Description
FB Suspension of granting procedure